Review
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Mar 26, 2025; 17(3): 103560
Published online Mar 26, 2025. doi: 10.4252/wjsc.v17.i3.103560
Immunomodulatory effects and clinical application of exosomes derived from mesenchymal stem cells
Yang-Fei Yi, Zi-Qi Fan, Can Liu, Yi-Tong Ding, Yao Chen, Jie Wen, Xiao-Hong Jian, Yu-Fei Li
Yang-Fei Yi, Zi-Qi Fan, Can Liu, Yi-Tong Ding, Yao Chen, Jie Wen, Xiao-Hong Jian, Yu-Fei Li, Department of Anatomy, Hunan Normal University School of Medicine, Changsha 410005, Hunan Province, China
Jie Wen, Department of Pediatric Orthopedics, Hunan Provincial People’s Hospital, Changsha 410013, Hunan Province, China
Co-first authors: Yang-Fei Yi and Zi-Qi Fan.
Co-corresponding authors: Jie Wen and Yu-Fei Li.
Author contributions: Yi YF and Fan ZQ contributed equally to this study as co-first authors. Yi YF contributed to the conceptualization; Fan ZQ contributed to the methodology; Liu C participated in the formal analysis; Ding YT took part in investigation; Chen Y curated the data; Wen J contributed to the resources; Jian XH was involved in validation of the manuscript; Li YF contributed to the supervision. Jian XH and Li YF contributed equally to this study as co-corresponding authors, and they revised the paper.
Supported by the National Natural Science Foundation of China, No. 82072537; and the General Project of Hunan Natural Science Foundation, No. 2022JJ30412 and No. 2021JJ30464.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jie Wen, PhD, Associate Professor, Department of Pediatric Orthopedics, Hunan Provincial People’s Hospital, No. 61 West Jiefang Road, Changsha 410013, Hunan Province, China. cashwj@qq.com
Received: November 25, 2024
Revised: January 16, 2025
Accepted: February 17, 2025
Published online: March 26, 2025
Processing time: 118 Days and 17 Hours
Abstract

Exosomes (Exos) are extracellular vesicles secreted by cells and serve as crucial mediators of intercellular communication. They play a pivotal role in the pathogenesis and progression of various diseases and offer promising avenues for therapeutic interventions. Exos derived from mesenchymal stem cells (MSCs) have significant immunomodulatory properties. They effectively regulate immune responses by modulating both innate and adaptive immunity. These Exos can inhibit excessive inflammatory responses and promote tissue repair. Moreover, they participate in antigen presentation, which is essential for activating immune responses. The cargo of these Exos, including ligands, proteins, and microRNAs, can suppress T cell activity or enhance the population of immunosuppressive cells to dampen the immune response. By inhibiting lymphocyte proliferation, acting on macrophages, and increasing the population of regulatory T cells, these Exos contribute to maintaining immune and metabolic homeostasis. Furthermore, they can activate immune-related signaling pathways or serve as vehicles to deliver microRNAs and other bioactive substances to target tumor cells, which holds potential for immunotherapy applications. Given the immense therapeutic potential of MSC-derived Exos, this review comprehensively explores their mechanisms of immune regulation and therapeutic applications in areas such as infection control, tumor suppression, and autoimmune disease management. This article aims to provide valuable insights into the mechanisms behind the actions of MSC-derived Exos, offering theoretical references for their future clinical utilization as cell-free drug preparations.

Keywords: Mesenchymal stem cells; Exosomes; Immunomodulatory effects; Clinical application; Therapeutic potential

Core Tip: Exosomes (Exos) are extracellular vesicles secreted by cells, and they serve as crucial mediators of intercellular communication, playing a pivotal role in the pathogenesis, progression, and therapeutic interventions for various diseases. Given the immense therapeutic potential of Exos derived from mesenchymal stem cells (MSC-Exos), this review article comprehensively explores mechanisms underlying their immune regulation as well as their therapeutic applications in infection control measures and tackling tumors or autoimmune diseases among others. This article aims to provide valuable insights into further investigations regarding the mechanism behind MSC-Exo actions while offering theoretical references for future clinical utilization of MSC-Exos as cell-free drug preparations.